1. Comparison of AMPLICOR® and Hybrid Capture II® assays for high risk HPV detection in normal and abnormal liquid-based cytology: Use of INNO-LiPA Genotyping assay to screen the discordant results
- Author
-
A. Petitjean, L. Z. Mo, Jean-Luc Prétet, Bernadette Kantelip, Christiane Mougin, Sylvain Monnier-Benoit, Didier Riethmuller, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), and Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC )
- Subjects
Inno lipa ,MESH: Reagent Kits, Diagnostic ,Bethesda system ,MESH : Aged ,Uterine Cervical Neoplasms ,MESH : Genotype ,Cervix Uteri ,MESH : Cervical Intraepithelial Neoplasia ,MESH: Papillomavirus Infections ,Polymerase Chain Reaction ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,MESH: Nucleic Acid Hybridization ,MESH: Genotype ,0302 clinical medicine ,MESH: Papillomaviridae ,Cytology ,MESH : Female ,MESH : Reagent Kits, Diagnostic ,Papillomaviridae ,MESH : Polymerase Chain Reaction ,MESH : Papillomavirus Infections ,MESH: Aged ,0303 health sciences ,MESH: Middle Aged ,medicine.diagnostic_test ,Hybrid capture ,Nucleic Acid Hybridization ,virus diseases ,MESH: Cervix Uteri ,Middle Aged ,MESH : Adult ,MESH : Nucleic Acid Hybridization ,female genital diseases and pregnancy complications ,3. Good health ,MESH: Uterine Cervical Neoplasms ,Infectious Diseases ,030220 oncology & carcinogenesis ,Liquid-based cytology ,MESH : Vaginal Smears ,Female ,MESH : Sensitivity and Specificity ,Nucleic Acid Amplification Techniques ,Adult ,Adolescent ,Genotype ,MESH: Vaginal Smears ,MESH : Uterine Cervical Neoplasms ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,Sensitivity and Specificity ,MESH: Nucleic Acid Amplification Techniques ,03 medical and health sciences ,MESH : Adolescent ,Virology ,medicine ,Humans ,MESH : Middle Aged ,Human papillomavirus ,MESH : Papillomaviridae ,Genotyping ,Aged ,030304 developmental biology ,Vaginal Smears ,MESH: Adolescent ,MESH: Humans ,Papillomavirus Infections ,MESH : Humans ,MESH: Adult ,MESH: Polymerase Chain Reaction ,MESH : Nucleic Acid Amplification Techniques ,Uterine Cervical Dysplasia ,MESH: Sensitivity and Specificity ,High risk hpv ,MESH : Cervix Uteri ,Reagent Kits, Diagnostic ,MESH: Cervical Intraepithelial Neoplasia ,MESH: Female - Abstract
International audience; The study was aimed to evaluate the feasibility of detecting human papillomavirus (HPV) in women with normal or abnormal cervical smears using the Roche Amplicor MWP HPV Test. We compared by AMPLICOR Test and Hybrid Capture II (HCII) Test, the prevalence of HR-HPV in 470 cervical samples including 55 samples with WNL cytology, 208 ASC-US, 193 LGSIL and 14 HGSIL. Samples with discordant results were retested with INNO-LiPA Genotyping HPV Test v2. The HR-HPV positivity in WNL cytology samples was similar (21.8%) by AMPLICOR and HCII. In ASC-US, the HPV positivity was 42.3% by both tests. In LGSIL, HPV positivity was 66.3% and 66.8% by AMPLICOR and HCII, respectively. In HGSIL, 92.8% of samples were positive by AMPLICOR and 85.7% by HCII. The agreement of both tests was 96.2% with a Kappa value of 0.92. Eighteen cases were discordant: 9 HCII positive/AMPLICOR negative and 9 HCII negative/AMPLICOR positive. The INNO-LiPA test revealed HPV positivity in every case. Interestingly, all HCII+/AMPLICOR- samples were found to harbour HPV53. As for the HCII-/AMPLICOR+ samples, 8 demonstrated a multiple infection with HR 16- and/or 18- and/or 56-phylogenetically related HPV types. Moreover, two of these samples were co-infected with HPV6 and two other with HPV54. By using consensus HR-HPV as our reference HPV positivity, the sensitivity (96.6%) and specificity (100%) of AMPLICOR was similar to that of HCII Test. The AMPLICOR HPV Test is sensitive, specific, feasible and appropriate for routine HPV detection.
- Published
- 2008